Novo Nordisk (Ondo Tokenized Stock)
NVOON
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
NVOON is an Ondo Global Markets tokenized equity product providing economic exposure to Novo Nordisk with automatic dividend reinvestment across Ethereum, BNB Chain, and Solana. The token benefits from solid operational vitality at the issuer level (7.5/10), a clean incident history with unbroken price parity against underlying shares (7.0/10), and the robust corporate governance of Novo Nordisk A/S backing the underlying equity (7.0/10). Tokenomics (6.5/10) operate on an asset-backed mint/redemption model with zero management fee drag, eliminating unlock overhang. However, the product is structurally constrained by design: it lacks any grassroots community or tokenholder voting rights (1.5/10), maintains a very small market capitalization of ~$2.35M-$2.45M with thin onchain liquidity (5.5/10), and carries centralized counterparty dependencies on Ondo's custodial framework without independent token-level audit reports. A June 2026 corporate IT breach at Novo Nordisk A/S did not compromise the token contract or shareholder assets, and no qualifying red-flag events were established. The overall score reflects the weighted average across all six evaluation sections.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About Novo Nordisk (Ondo Tokenized Stock) (NVOON)
NVOON (Novo Nordisk (Ondo Tokenized Stock)) is a real-world asset (RWA) token issued by Ondo Finance under its Ondo Global Markets platform. Launched in July 2025, the token operates across Ethereum, BNB Chain, and Solana to provide holders with economic exposure to the equity of pharmaceutical company Novo Nordisk A/S with reinvested dividends. The token uses an asset-backed mint and redemption mechanism where supply expands or contracts based on underlying shares held by regulated custodial broker-dealers, rather than following a fixed supply schedule.
The token features no management or performance fees and is designed to track the net asset value of the underlying equity. It maintains a circulating supply of approximately 49,000 to 51,000 tokens and a total tokenized market capitalization of roughly $2.35 million to $2.45 million. Onchain adoption and liquidity remain limited, with around 270 holders and low decentralized finance composability, serving primarily as a channel for non-U.S. market participants seeking continuous onchain exposure to the stock.
The token's structure involves centralized dependencies on Ondo Finance for issuance, redemption, and custodial oversight, with no onchain governance or shareholder voting rights granted to tokenholders. Furthermore, no third-party smart contract security audit reports specific to the NVOON contract were identified in available documentation. While the token contract has suffered no exploits, depegs, or exchange delistings, the underlying corporation, Novo Nordisk A/S, disclosed a corporate IT security incident in June 2026 involving unauthorized access to internal systems, in which an external cybercrime group claimed the theft of approximately 1.3 terabytes of data. NVOON is also subject to jurisdictional restrictions that exclude U.S. persons.